Loading…

GABA sub(B) receptor cell-surface export is controlled by an endoplasmic reticulum gatekeeper

Endoplasmic reticulum (ER) release and cell-surface export of many G protein-coupled receptors (GPCRs) are tightly regulated. For gamma-aminobutyric acid (GABA) sub(B) receptors of GABA, the major mammalian inhibitory neurotransmitter, the ligand-binding GB1 subunit is maintained in the ER by unknow...

Full description

Saved in:
Bibliographic Details
Published in:Molecular psychiatry 2016-04, Vol.21 (4), p.480-490
Main Authors: Doly, S, Shirvani, H, Gaeta, G, Meye, F J, Emerit, M-B, Enslen, H, Achour, L, Pardo-Lopez, L, Yang, S-K, Armand, V, Gardette, R, Giros, B, Gassmann, M, Bettler, B, Mameli, M, Darmon, M, Marullo, S
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Endoplasmic reticulum (ER) release and cell-surface export of many G protein-coupled receptors (GPCRs) are tightly regulated. For gamma-aminobutyric acid (GABA) sub(B) receptors of GABA, the major mammalian inhibitory neurotransmitter, the ligand-binding GB1 subunit is maintained in the ER by unknown mechanisms in the absence of hetero-dimerization with the GB2 subunit. We report that GB1 retention is regulated by a specific gatekeeper, PRAF2. This ER resident transmembrane protein binds to GB1, preventing its progression in the biosynthetic pathway. GB1 release occurs upon competitive displacement from PRAF2 by GB2. PRAF2 concentration, relative to that of GB1 and GB2, tightly controls cell-surface receptor density and controls GABA sub(B) function in neurons. Experimental perturbation of PRAF2 levels in vivo caused marked hyperactivity disorders in mice. These data reveal an unanticipated major impact of specific ER gatekeepers on GPCR function and identify PRAF2 as a new molecular target with therapeutic potential for psychiatric and neurological diseases involving GABA sub(B) function.
ISSN:1359-4184
DOI:10.1038/mp.2015.72